World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
112
Citations
49052
World Ranking
5127
National Ranking
53

Matti Aapro publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Matti Aapro sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 667 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Matti Aapro D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Matti Aapro sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 112 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Matti Aapro is affiliated with the European CanCer Organisation in Belgium and focuses primarily on research in Medicine, with a significant contribution to the field of Oncology. Their work spans multiple subfields including Surgery, Economics and Econometrics, Pulmonary and Respiratory Medicine, and Physiology. The overall scope reflects a multidisciplinary approach to cancer research and patient care.

The main topics addressed in their research include:

  • Nausea and vomiting management
  • Anesthesia and pain management
  • Advances in oncology and radiotherapy
  • Breast cancer treatment studies
  • Economic and financial impacts of cancer
  • Pathogenesis and treatment of hiccups
  • Cancer treatment and pharmacology

Matti Aapro has published extensively in several journals, with frequent contributions to:

  • Supportive Care in Cancer
  • Annals of Oncology
  • The Breast
  • Critical Reviews in Oncology/Hematology
  • The Oncologist

Notable recent publications include:

  • "5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)," 2020, Annals of Oncology
  • "Bone health in cancer: ESMO Clinical Practice Guidelines," 2020, Annals of Oncology
  • "Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives," 2020, Supportive Care in Cancer
  • "Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)," 2021, The Lancet Oncology
  • "4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4)," 2021, UNC Libraries

Collaboration appears as an important aspect of their work, with frequent co-authors including:

  • Alberto Costa
  • Fátima Cardoso
  • Alexandru Eniu
  • Nicholas Pavlidis
  • Fedro A. Peccatori

The research output demonstrates a consistent focus on cancer treatment, supportive care, and the economic dimensions of oncology. The combination of clinical guidelines, consensus papers, and investigations into digital health solutions highlights a broad interest in both patient management and systemic healthcare improvements within oncology.

Best Publications

  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    F. Cardoso;A. Costa;E. Senkus;M. Aapro

  • 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

    M. S. Aapro;J. Bohlius;David Cameron;Lissandra Dal Lago

  • Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

    Martine Extermann;Matti Aapro;Roberto Bernabei;Harvey Jay Cohen

  • Comprehensive Geriatric Assessment Adds Information to Eastern Cooperative Oncology Group Performance Status in Elderly Cancer Patients: An Italian Group for Geriatric Oncology Study

    Lazzaro Repetto;Lucia Fratino;Riccardo A. Audisio;Antonella Venturino

  • Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

    F. Roila;J. Herrstedt;M. Aapro;R. J. Gralla

  • Proposal for classifying the acute emetogenicity of cancer chemotherapy.

    Paul J. Hesketh;Mark G. Kris;Steven M. Grunberg;Thomas Beck

  • Delivering affordable cancer care in high-income countries

    Richard Sullivan;Jeffrey Peppercorn;Karol Sikora;John Zalcberg

  • ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

    F. Cardoso;A. Costa;L. Norton;E. Senkus

  • Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

    Jean Klastersky;J. de Naurois;Kenneth Rolston;Bernardo Leon B. Rapoport

  • Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

    J.-M. Nabholtz;H. J. Senn;W. R. Bezwoda;D. Melnychuk

  • EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

    Matti Aapro;David A Cameron;Ruth Pettengell;Julia Bohlius

  • Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

    Laura Biganzoli;Hans Wildiers;Catherine Oakman;Lorenza Marotti

  • Integration of oncology and palliative care: a Lancet Oncology Commission

    Stein Kaasa;Jon Håvard Loge;Matti S. Aapro;Tit Albreht

  • Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

    R. Gralla;M. Lichinitser;S. Van der Vegt;H. Sleeboom

  • Bone health in cancer patients: ESMO Clinical Practice Guidelines

    R Coleman;Jean-Jacques Body;M Aapro;P Hadji

  • Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

    M. Aapro;P. A. Abrahamsson;J. J. Body;R. E. Coleman

  • 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

    F. Roila;A. Molassiotis;J. Herrstedt;M. Aapro

  • EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

    C. Bokemeyer;M.S. Aapro;A. Courdi;J. Foubert

  • A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

    M S Aapro;S M Grunberg;G M Manikhas;G Olivares

  • 進行性乳癌のためのESO-ESMO国際コンセンサスガイドライン第四版(ABC 4)

    F Cardoso;E Senkus;A Costa;E Papadopoulos

Frequent Co-Authors

Heinz Ludwig
Heinz Ludwig University of Vienna
Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Robert E. Coleman
Robert E. Coleman University of Sheffield
Lodovico Balducci
Lodovico Balducci University of South Florida
Carsten Bokemeyer
Carsten Bokemeyer Universität Hamburg
Alex Molassiotis
Alex Molassiotis Hong Kong Polytechnic University
Jean-Jacques Body
Jean-Jacques Body Université Libre de Bruxelles
Hans Wildiers
Hans Wildiers KU Leuven
Martine Piccart
Martine Piccart Université Libre de Bruxelles
Anders Österborg
Anders Österborg Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens the door to many healthcare-related pathways. Professionals looking to specialize in mental health might consider the shortest post master's pmhnp online programs, which allow for a streamlined route to becoming a psychiatric nurse practitioner. These programs can be ideal for nurses aiming to broaden their advanced clinical skills in mental health care.

For those interested in healthcare management and administration roles, pursuing a bachelors in healthcare administration provides foundational knowledge in healthcare systems and leadership. Graduates often further their expertise through online mha programs affordable, which are designed to equip professionals with advanced skills for leadership positions in hospitals, clinics, and beyond.

For registered nurses seeking the highest clinical qualifications, the cheapest bsn to dnp programs offer a cost-effective way to achieve a Doctor of Nursing Practice. This degree prepares nurses for specialized, high-level practice and leadership roles in healthcare.

Each of these pathways combines career advancement potential with the flexibility and affordability of online study, making them attractive options for aspiring and current healthcare professionals.

Best Scientists Citing Matti Aapro

Trending Scientists

Recently Published Articles